Business Segments · Depreciation
Cardiovascular — Depreciation
Medtronic Cardiovascular — Depreciation increased by 17.9% to $66.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 17.9%, from $56.00M to $66.00M. Over 3 years (FY 2021 to FY 2025), Cardiovascular — Depreciation shows an upward trend with a 4.2% CAGR.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2020
Last reportedQ1 2026
How to read this metric
High depreciation relative to revenue may indicate a capital-intensive manufacturing process or recent heavy investment in infrastructure.
Detailed definition
This represents the systematic allocation of the cost of tangible assets, such as manufacturing equipment and facilities...
Peer comparison
Comparable to depreciation charges in the segment reporting of capital-intensive healthcare manufacturers.
Metric ID:
mdt_segment_cardiovascular_depreciationHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $53.00M | $53.00M | $53.00M | $53.50M | $53.50M | $53.50M | $53.50M | $53.00M | $53.00M | $53.00M | $53.00M | $55.00M | $56.00M | $56.00M | $64.00M | $64.00M | $56.00M | $66.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.9% | +0.0% | +0.0% | +0.0% | -0.9% | +0.0% | +0.0% | +0.0% | +3.8% | +1.8% | +0.0% | +14.3% | +0.0% | -12.5% | +17.9% |
| YoY Change | — | — | — | — | +0.9% | +0.9% | +0.9% | -0.9% | -0.9% | -0.9% | -0.9% | +3.8% | +5.7% | — | — | +16.4% | +0.0% | +17.9% |
Range$53.00M – $66.00M
CAGR+5.3%
Avg YoY Growth+3.6%
Median YoY Growth+0.9%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Medtronic's cardiovascular — depreciation?
- Medtronic (MDT) reported cardiovascular — depreciation of $66.00M in Q1 2026.
- How has Medtronic's cardiovascular — depreciation changed year-over-year?
- Medtronic's cardiovascular — depreciation increased by 17.9% year-over-year, from $56.00M to $66.00M.
- What is the long-term trend for Medtronic's cardiovascular — depreciation?
- Over 3 years (2021 to 2025), Medtronic's cardiovascular — depreciation has grown at a 4.2% compound annual growth rate (CAGR), from $212.00M to $240.00M.
- What does cardiovascular — depreciation mean?
- The non-cash expense representing the wear and tear of physical assets used in the cardiovascular segment.